help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vlahou, A.
Right arrow Articles by Wright, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vlahou, A.
Right arrow Articles by Wright, G. L., Jr.
(American Journal of Pathology. 2001;158:1491-1502.)
© 2001 American Society for Investigative Pathology

Regular Articles

Development of a Novel Proteomic Approach for the Detection of Transitional Cell Carcinoma of the Bladder in Urine

Antonia Vlahou*§, Paul F. Schellhammer{dagger}§, Savvas Mendrinos{ddagger}, Keyur Patel{ddagger}, Filippos I. Kondylis{dagger}, Lei Gong*, Suhail Nasim{ddagger} and George L. Wright Jr.*{dagger}§

From the Departments of Microbiology and Molecular Cell Biology,*
Urology,{dagger}
and Pathology,{ddagger}
Eastern Virginia Medical School, Norfolk; and the Virginia Prostate Center,§
Norfolk, Virginia

Development of noninvasive methods for the diagnosis of transitional cell carcinoma (TCC) of the bladder remains a challenge. A ProteinChip technology (surface enhanced laser desorption/ionization time of flight mass spectrometry) has recently been developed to facilitate protein profiling of biological mixtures. This report describes an exploratory study of this technology as a TCC diagnostic tool. Ninety-four urine samples from patients with TCC, patients with other urogenital diseases, and healthy donors were analyzed. Multiple protein changes were reproducibly detected in the TCC group, including five potential novel TCC biomarkers and seven protein clusters (mass range, 3.3 to 133 kd). One of the TCC biomarkers (3.4 kd) was also detected in bladder cancer cells procured from bladder barbotage and was identified as defensin. The TCC detection rates provided by the individual markers ranged from 43 to 70% and specificities from 70 to 86%. Combination of the protein biomarkers and clusters, increased significantly the sensitivity for detecting TCC to 87% with a specificity of 66%. Interestingly, this combinatorial approach provided sensitivity of 78% for detecting low-grade TCC compared to only 33% of voided urine or bladder-washing cytology. Collectively these results support the potential of this proteomic approach for the development of a highly sensitive urinary TCC diagnostic test.




This article has been cited by other articles:


Home page
 Clin. Chem.Home page
D. McLerran, W. E. Grizzle, Z. Feng, W. L. Bigbee, L. L. Banez, L. H. Cazares, D. W. Chan, J. Diaz, E. Izbicka, J. Kagan, et al.
Analytical Validation of Serum Proteomic Profiling for Diagnosis of Prostate Cancer: Sources of Sample Bias
Clin. Chem., January 1, 2008; 54(1): 44 - 52.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D. Fliser, J. Novak, V. Thongboonkerd, A. Argiles, V. Jankowski, M. A. Girolami, J. Jankowski, and H. Mischak
Advances in Urinary Proteome Analysis and Biomarker Discovery
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1057 - 1071.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
K. Mosley, F. W. K. Tam, R. J. Edwards, J. Crozier, C. D. Pusey, and L. Lightstone
Urinary proteomic profiles distinguish between active and inactive lupus nephritis
Rheumatology, December 1, 2006; 45(12): 1497 - 1504.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Jahnukainen, D. Malehorn, M. Sun, J. Lyons-Weiler, W. Bigbee, G. Gupta, R. Shapiro, P. S. Randhawa, R. Pelikan, M. Hauskrecht, et al.
Proteomic Analysis of Urine in Kidney Transplant Patients with BK Virus Nephropathy
J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3248 - 3256.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
N. S. Azad, N. Rasool, C. M. Annunziata, L. Minasian, G. Whiteley, and E. C. Kohn
Proteomics in Clinical Trials and Practice: Present Uses and Future Promise
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1819 - 1829.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
T. Pisitkun, R. Johnstone, and M. A. Knepper
Discovery of Urinary Biomarkers
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1760 - 1771.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
M. Bellew, M. Coram, M. Fitzgibbon, M. Igra, T. Randolph, P. Wang, D. May, J. Eng, R. Fang, C. Lin, et al.
A suite of algorithms for the comprehensive analysis of complex protein mixtures using high-resolution LC-MS
Bioinformatics, August 1, 2006; 22(15): 1902 - 1909.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
U. Muller, G. Ernst, C. Melle, R. Guthke, and F. von Eggeling
Convergence of the proteomic pattern in cancer
Bioinformatics, June 1, 2006; 22(11): 1293 - 1296.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
G. Ernst, C. Melle, B. Schimmel, A. Bleul, and F. von Eggeling
Proteohistography--Direct Analysis of Tissue with High Sensitivity and High Spatial Resolution Using ProteinChip Technology
J. Histochem. Cytochem., January 1, 2006; 54(1): 13 - 17.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Li, J. Zhao, X. Yu, J. Lange, H. Kuerer, S. Krishnamurthy, E. Schilling, S. A. Khan, S. Sukumar, and D. W. Chan
Identification of Biomarkers for Breast Cancer in Nipple Aspiration and Ductal Lavage Fluid
Clin. Cancer Res., December 1, 2005; 11(23): 8312 - 8320.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Li, R. Orlandi, C. N. White, J. Rosenzweig, J. Zhao, E. Seregni, D. Morelli, Y. Yu, X.-Y. Meng, Z. Zhang, et al.
Independent Validation of Candidate Breast Cancer Serum Biomarkers Identified by Mass Spectrometry
Clin. Chem., December 1, 2005; 51(12): 2229 - 2235.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. L. Hortin and B. Meilinger
Cross-Reactivity of Amino Acids and Other Compounds in the Biuret Reaction: Interference with Urinary Peptide Measurements
Clin. Chem., August 1, 2005; 51(8): 1411 - 1419.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Malik, M. D. Ward, S. K. Gupta, M. W. Trosset, W. E. Grizzle, B.-L. Adam, J. I. Diaz, and O. J. Semmes
Serum Levels of an Isoform of Apolipoprotein A-II as a Potential Marker for Prostate Cancer
Clin. Cancer Res., February 1, 2005; 11(3): 1073 - 1085.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. M. Koomen, L. N. Shih, K. R. Coombes, D. Li, L.-c. Xiao, I. J. Fidler, J. L. Abbruzzese, and R. Kobayashi
Plasma Protein Profiling for Diagnosis of Pancreatic Cancer Reveals the Presence of Host Response Proteins
Clin. Cancer Res., February 1, 2005; 11(3): 1110 - 1118.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
O. J. Semmes, Z. Feng, B.-L. Adam, L. L. Banez, W. L. Bigbee, D. Campos, L. H. Cazares, D. W. Chan, W. E. Grizzle, E. Izbicka, et al.
Evaluation of Serum Protein Profiling by Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for the Detection of Prostate Cancer: I. Assessment of Platform Reproducibility
Clin. Chem., January 1, 2005; 51(1): 102 - 112.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
E. O'Riordan, T. N. Orlova, J. Mei J, K. Butt, P. M. Chander, S. Rahman, M. Mya, R. Hu, J. Momin, E. W. Eng, et al.
Bioinformatic Analysis of the Urine Proteome of Acute Allograft Rejection
J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3240 - 3248.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Zhang, R. C. Bast Jr., Y. Yu, J. Li, L. J. Sokoll, A. J. Rai, J. M. Rosenzweig, B. Cameron, Y. Y. Wang, X.-Y. Meng, et al.
Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
Cancer Res., August 15, 2004; 64(16): 5882 - 5890.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Vlahou, A. Giannopoulos, B. W. Gregory, T. Manousakas, F. I. Kondylis, L. L. Wilson, P. F. Schellhammer, G. L. Wright Jr, and O. J. Semmes
Protein Profiling in Urine for the Diagnosis of Bladder Cancer
Clin. Chem., August 1, 2004; 50(8): 1438 - 1441.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. G. Soltys, Q.-T. Le, G. Shi, R. Tibshirani, A. J. Giaccia, and A. C. Koong
The Use of Plasma Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Proteomic Patterns for Detection of Head and Neck Squamous Cell Cancers
Clin. Cancer Res., July 15, 2004; 10(14): 4806 - 4812.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Melle, G. Ernst, B. Schimmel, A. Bleul, S. Koscielny, A. Wiesner, R. Bogumil, U. Moller, D. Osterloh, K.-J. Halbhuber, et al.
A Technical Triade for Proteomic Identification and Characterization of Cancer Biomarkers
Cancer Res., June 15, 2004; 64(12): 4099 - 4104.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. P. Diamandis
How Are We Going to Discover New Cancer Biomarkers? A Proteomic Approach for Bladder Cancer
Clin. Chem., May 1, 2004; 50(5): 793 - 795.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. T. Wadsworth, K. D. Somers, L. H. Cazares, G. Malik, B.-L. Adam, B. C. Stack Jr., G. L. Wright Jr., and O. J. Semmes
Serum Protein Profiles to Identify Head and Neck Cancer
Clin. Cancer Res., March 1, 2004; 10(5): 1625 - 1632.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Koopmann, Z. Zhang, N. White, J. Rosenzweig, N. Fedarko, S. Jagannath, M. I. Canto, C. J. Yeo, D. W. Chan, and M. Goggins
Serum Diagnosis of Pancreatic Adenocarcinoma Using Surface-Enhanced Laser Desorption and Ionization Mass Spectrometry
Clin. Cancer Res., February 1, 2004; 10(3): 860 - 868.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
J. T. Wadsworth, K. D. Somers, B. C. Stack Jr, L. Cazares, G. Malik, B.-L. Adam, G. L. Wright Jr, and O. J. Semmes
Identification of Patients With Head and Neck Cancer Using Serum Protein Profiles
Arch Otolaryngol Head Neck Surg, January 1, 2004; 130(1): 98 - 104.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. A. Rogers, P. Clarke, J. Noble, N. P. Munro, A. Paul, P. J. Selby, and R. E. Banks
Proteomic Profiling of Urinary Proteins in Renal Cancer by Surface Enhanced Laser Desorption Ionization and Neural-Network Analysis: Identification of Key Issues Affecting Potential Clinical Utility
Cancer Res., October 15, 2003; 63(20): 6971 - 6983.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. R. Kozak, M. W. Amneus, S. M. Pusey, F. Su, M. N. Luong, S. A. Luong, S. T. Reddy, and R. Farias-Eisner
Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis
PNAS, October 14, 2003; 100(21): 12343 - 12348.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. Ye, D. W. Cramer, S. J. Skates, S. P. Gygi, V. Pratomo, L. Fu, N. K. Horick, L. J. Licklider, J. O. Schorge, R. S. Berkowitz, et al.
Haptoglobin-{alpha} Subunit As Potential Serum Biomarker in Ovarian Cancer: Identification and Characterization Using Proteomic Profiling and Mass Spectrometry
Clin. Cancer Res., August 1, 2003; 9(8): 2904 - 2911.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
C. Melle, G. Ernst, B. Schimmel, A. Bleul, S. Koscielny, A. Wiesner, R. Bogumil, U. Moller, D. Osterloh, K.-J. Halbhuber, et al.
Biomarker Discovery and Identification in Laser Microdissected Head and Neck Squamous Cell Carcinoma with ProteinChip(R) Technology, Two-dimensional Gel Electrophoresis, Tandem Mass Spectrometry, and Immunohistochemistry
Mol. Cell. Proteomics, July 1, 2003; 2(7): 443 - 452.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. J. Duggan, J. J. McKnight, K. E. Williamson, M. Loughrey, D. O'Rourke, P. W. Hamilton, S. R. Johnston, C. C. Schulman, and A. R. Zlotta
The Need to Embrace Molecular Profiling of Tumor Cells in Prostate and Bladder Cancer
Clin. Cancer Res., April 1, 2003; 9(4): 1240 - 1247.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
Y. Qu, B.-L. Adam, Y. Yasui, M. D. Ward, L. H. Cazares, P. F. Schellhammer, Z. Feng, O. J. Semmes, and G. L. Wright Jr.
Boosted Decision Tree Analysis of Surface-enhanced Laser Desorption/Ionization Mass Spectral Serum Profiles Discriminates Prostate Cancer from Noncancer Patients
Clin. Chem., October 1, 2002; 48(10): 1835 - 1843.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Li, Z. Zhang, J. Rosenzweig, Y. Y. Wang, and D. W. Chan
Proteomics and Bioinformatics Approaches for Identification of Serum Biomarkers to Detect Breast Cancer
Clin. Chem., August 1, 2002; 48(8): 1296 - 1304.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. H. Cazares, B.-L. Adam, M. D. Ward, S. Nasim, P. F. Schellhammer, O. J. Semmes, and G. L. Wright Jr.
Normal, Benign, Preneoplastic, and Malignant Prostate Cells Have Distinct Protein Expression Profiles Resolved by Surface Enhanced Laser Desorption/Ionization Mass Spectrometry
Clin. Cancer Res., August 1, 2002; 8(8): 2541 - 2552.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
T. K. Bane, J. F. LeBlanc, T. D. Lee, and A. D. Riggs
DNA affinity capture and protein profiling by SELDI-TOF mass spectrometry: effect of DNA methylation
Nucleic Acids Res., July 15, 2002; 30(14): e69 - e69.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B.-L. Adam, Y. Qu, J. W. Davis, M. D. Ward, M. A. Clements, L. H. Cazares, O. J. Semmes, P. F. Schellhammer, Y. Yasui, Z. Feng, et al.
Serum Protein Fingerprinting Coupled with a Pattern-matching Algorithm Distinguishes Prostate Cancer from Benign Prostate Hyperplasia and Healthy Men
Cancer Res., July 1, 2002; 62(13): 3609 - 3614.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Rosty, L. Christa, S. Kuzdzal, W. M. Baldwin, M. L. Zahurak, F. Carnot, D. W. Chan, M. Canto, K. D. Lillemoe, J. L. Cameron, et al.
Identification of Hepatocarcinoma-Intestine-Pancreas/Pancreatitis-associated Protein I as a Biomarker for Pancreatic Ductal Adenocarcinoma by Protein Biochip Technology
Cancer Res., March 1, 2002; 62(6): 1868 - 1875.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. R. Srinivas, S. Srivastava, S. Hanash, and G. L. Wright Jr
Proteomics in Early Detection of Cancer
Clin. Chem., October 1, 2001; 47(10): 1901 - 1911.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society for Investigative Pathology.